These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 11327725

  • 21. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
    Oh H, Takagi H, Otani A, Koyama S, Kemmochi S, Uemura A, Honda Y.
    Proc Natl Acad Sci U S A; 2002 Jan 08; 99(1):383-8. PubMed ID: 11756651
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action.
    Waltenberger J, Mayr U, Frank H, Hombach V.
    J Mol Cell Cardiol; 1996 Jul 08; 28(7):1523-9. PubMed ID: 8841939
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T.
    Circ Res; 2003 Sep 05; 93(5):438-47. PubMed ID: 12881481
    [Abstract] [Full Text] [Related]

  • 26. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
    Grosskreutz CL, Anand-Apte B, Dupláa C, Quinn TP, Terman BI, Zetter B, D'Amore PA.
    Microvasc Res; 1999 Sep 05; 58(2):128-36. PubMed ID: 10458928
    [Abstract] [Full Text] [Related]

  • 27. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
    Devadas K, Boykins RA, Hardegen NJ, Philp D, Kleinman HK, Osa EO, Wang J, Clouse KA, Wahl LM, Hewlett IK, Rappaport J, Yamada KM, Dhawan S.
    Peptides; 2006 Apr 05; 27(4):611-21. PubMed ID: 16256245
    [Abstract] [Full Text] [Related]

  • 28. Rho family GTPases regulate VEGF-stimulated endothelial cell motility.
    Soga N, Namba N, McAllister S, Cornelius L, Teitelbaum SL, Dowdy SF, Kawamura J, Hruska KA.
    Exp Cell Res; 2001 Sep 10; 269(1):73-87. PubMed ID: 11525641
    [Abstract] [Full Text] [Related]

  • 29. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
    Siemeister G, Schnurr B, Mohrs K, Schächtele C, Marmé D, Martiny-Baron G.
    Biochem Biophys Res Commun; 1996 May 15; 222(2):249-55. PubMed ID: 8670191
    [Abstract] [Full Text] [Related]

  • 30. Bacterial wall products induce downregulation of vascular endothelial growth factor receptors on endothelial cells via a CD14-dependent mechanism: implications for surgical wound healing.
    Power C, Wang JH, Sookhai S, Street JT, Redmond HP.
    J Surg Res; 2001 Dec 15; 101(2):138-45. PubMed ID: 11735268
    [Abstract] [Full Text] [Related]

  • 31. HIV TAT basic peptide is not a high-affinity ligand for VEGF receptor 2.
    Rubio Demirovic A, Canadi J, Weiglhofer W, Scheidegger P, Jaussi R, Kurt BH.
    Biol Chem; 2003 Dec 15; 384(10-11):1435-41. PubMed ID: 14669986
    [Abstract] [Full Text] [Related]

  • 32. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
    Giatromanolaki A, Sivridis E, Athanassou N, Zois E, Thorpe PE, Brekken RA, Gatter KC, Harris AL, Koukourakis IM, Koukourakis MI.
    J Pathol; 2001 May 15; 194(1):101-8. PubMed ID: 11329148
    [Abstract] [Full Text] [Related]

  • 33. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
    Sasaki A, Taketomi T, Kato R, Saeki K, Nonami A, Sasaki M, Kuriyama M, Saito N, Shibuya M, Yoshimura A.
    Nat Cell Biol; 2003 May 15; 5(5):427-32. PubMed ID: 12717443
    [Abstract] [Full Text] [Related]

  • 34. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.
    Cancer Res; 2002 Dec 01; 62(23):6884-90. PubMed ID: 12460903
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
    Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoemaker S, Ramirez RA, Ip MM.
    Cancer Res; 2002 Aug 01; 62(15):4383-9. PubMed ID: 12154044
    [Abstract] [Full Text] [Related]

  • 36. Effect of FGF-1 and FGF-2 on VEGF binding to human umbilical vein endothelial cells.
    Chen JH, Wang XC, Kan M, Sato JD.
    Cell Biol Int; 2001 Aug 01; 25(3):257-60. PubMed ID: 11352499
    [Abstract] [Full Text] [Related]

  • 37. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J, Blaskovich MA, Jain RK, Delarue F, Paris D, Brem S, Wotoczek-Obadia M, Lin Q, Coppola D, Choi K, Mullan M, Hamilton AD, Sebti SM.
    Cancer Res; 2004 May 15; 64(10):3586-92. PubMed ID: 15150116
    [Abstract] [Full Text] [Related]

  • 38. Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells.
    Wang D, Lehman RE, Donner DB, Matli MR, Warren RS, Welton ML.
    Am J Physiol Gastrointest Liver Physiol; 2002 Jun 15; 282(6):G1088-96. PubMed ID: 12016135
    [Abstract] [Full Text] [Related]

  • 39. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.
    Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D.
    Nat Med; 2001 May 15; 7(5):569-74. PubMed ID: 11329058
    [Abstract] [Full Text] [Related]

  • 40. Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: implications for Tat-mediated pathogenesis.
    Benelli R, Barbero A, Ferrini S, Scapini P, Cassatella M, Bussolino F, Tacchetti C, Noonan DM, Albini A.
    J Infect Dis; 2000 Dec 15; 182(6):1643-51. PubMed ID: 11069235
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.